Valuation: Sartorius AG

Market Cap 16.41B 18.65B 15.47B 14.11B 26.39B 1,790B 26.59B 186B 71.92B 911B 70.03B 68.51B 2,965B P/E 2026 *
70x
P/E 2027 * 53.8x
Enterprise Value 19.98B 22.72B 18.84B 17.18B 32.14B 2,181B 32.39B 226B 87.59B 1,110B 85.29B 83.44B 3,611B EV / Sales 2026 *
5.37x
EV / Sales 2027 * 4.82x
Free-Float
35.87%
Yield 2026 *
0.3%
Yield 2027 * 0.37%
1 day+1.69%
1 week+7.16%
Current month+2.10%
1 month+2.10%
3 months+13.18%
6 months+11.09%
Current year+2.68%
1 week 275.96
Extreme 275.9595
275.96
1 month 257.53
Extreme 257.53
275.96
Current year 233.92
Extreme 233.92
312.93
1 year 226.38
Extreme 226.375
312.93
3 years 198.85
Extreme 198.8499
423.7
5 years 198.85
Extreme 198.8499
736.22
10 years 74.75
Extreme 74.75
736.22
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2025
Director of Finance/CFO 55 01/04/2024
Chief Operating Officer 70 01/01/2001
Director TitleAgeSince
Director/Board Member 62 01/09/2002
Chairman 69 19/07/2017
Director/Board Member 77 29/11/2011
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%+7.16% - - 18.65B
-0.85%+7.80%+36.06%-15.58% 18.65B
-5.20%-1.26%-40.28%+23.38% 1.85B
-0.53%0.00%-30.46%+23.09% 866M
-0.03%-0.38%+50.65%-1.91% 778M
-0.98%-3.61%-59.95%-85.08% 733M
-0.69%+8.32%-30.46%-46.60% 686M
+1.77%+5.45%-38.77%-51.24% 589M
-0.65%+4.92%+52.38%+90.73% 476M
+4.51%+5.88%-1.59%+8.00% 399M
Average -0.07%+2.21%-6.94%-6.13% 2.78B
Weighted average by Cap. +0.34%+5.29%+21.89%-12.27%

Financials

2026 *2027 *
Net sales 3.72B 4.23B 3.51B 3.2B 5.99B 406B 6.03B 42.12B 16.32B 207B 15.89B 15.55B 673B 4.08B 4.64B 3.85B 3.51B 6.57B 446B 6.62B 46.19B 17.9B 227B 17.43B 17.05B 738B
Net income 255M 290M 241M 220M 411M 27.87B 414M 2.89B 1.12B 14.18B 1.09B 1.07B 46.16B 329M 374M 310M 283M 529M 35.86B 533M 3.72B 1.44B 18.25B 1.4B 1.37B 59.39B
Net Debt 3.58B 4.06B 3.37B 3.07B 5.75B 390B 5.8B 40.44B 15.67B 199B 15.26B 14.93B 646B 3.27B 3.72B 3.08B 2.81B 5.26B 357B 5.3B 36.99B 14.33B 182B 13.96B 13.65B 591B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
21/09/26 $275.96 +1.69% 85
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
265.30EUR
Average target price
271.74EUR
Spread / Average Target
+2.43%

Quarterly revenue - Rate of surprise